DeltaFlu DelNS1 H5N1 Delta-19

 

Pattern-04.png
“News”
Featured
Vivaldi Biosciences Granted U.S. Patent for Nasal Spray Combination Vaccine for Influenza and COVID-19
Vivaldi Biosciences Granted U.S. Patent for Nasal Spray Combination Vaccine for Influenza and COVID-19
Read more →
Innovations for Clinical Development of a Broadly Protective Nasal Spray Flu Vaccine to be Presented by Vivaldi Biosciences at ISRV Options XIII Conference
Innovations for Clinical Development of a Broadly Protective Nasal Spray Flu Vaccine to be Presented by Vivaldi Biosciences at ISRV Options XIII Conference
Read more →
Vivaldi Biosciences Granted U.S. Patent for Universal Influenza Vaccine
Vivaldi Biosciences Granted U.S. Patent for Universal Influenza Vaccine
Read more →
Vivaldi Biosciences to Present DeltaFLU Universal Influenza Vaccine Study Results at ISRV Meeting
Vivaldi Biosciences to Present DeltaFLU Universal Influenza Vaccine Study Results at ISRV Meeting
Read more →
Vivaldi Biosciences Announces Issuance of U.S. Patent Enabling Rapid Manufacture of its Universal Influenza Vaccine
Vivaldi Biosciences Announces Issuance of U.S. Patent Enabling Rapid Manufacture of its Universal Influenza Vaccine
Read more →
Vivaldi Biosciences’ Universal Influenza Vaccine Shows Potential to Block Virus Transmission and Disease Spread
Vivaldi Biosciences’ Universal Influenza Vaccine Shows Potential to Block Virus Transmission and Disease Spread
Read more →
Slide17.png
Read more →
Slide11.png
Read more →
Vivaldi Biosciences to Present Universal Influenza Vaccine Data at World Vaccine Congress
Vivaldi Biosciences to Present Universal Influenza Vaccine Data at World Vaccine Congress
Read more →
Slide16.png
Read more →
Slide11.png
Read more →
Slide9.png
Read more →
Featured
Slide10.png
Read more →
Slide14.png
Read more →
Slide08.png
Read more →
Slide06.png
Read more →
Slide05.png
Read more →
Slide03.png
Read more →
Slide02.png
Read more →
Slide01.png
Read more →

 

 

Pattern-04.png